New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTMAA, ATVI, GES, WLK, IGT, MFC, LNKD, RNST, PCS, BIIB, AVB, NTES, EQR, BCS, ARMH, UDR, LRE, DFS, BRE, ACMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AECOM Technology (ACM) upgraded to Buy from Underperform at BofA/Merrill... ARM Holdings (ARMH) upgraded to Outperform from Neutral at Credit Suisse... AvalonBay (AVB) upgraded to Buy from Neutral at UBS... BRE Properties (BRE) upgraded to Buy from Neutral at UBS... Barclays (BCS) upgraded to Neutral from Underperform at Macquarie... Biogen (BIIB) upgraded to Buy from Neutral at Citigroup... Discover (DFS) upgraded to Outperform from Neutral at Credit Suisse... Equity Residential (EQR) upgraded to Buy from Neutral at UBS... LRR Energy (LRE) upgraded to Outperform from Neutral at RW Baird... MetroPCS (PCS) upgraded to Neutral from Reduce at Nomura... NetEase.com (NTES) upgraded to Buy from Hold at Deutsche Bank... Renasant (RNST) upgraded to Buy from Hold at Wunderlich... UDR, Inc. (UDR) upgraded to Buy from Neutral at UBS... Westlake Chemical (WLK) upgraded to Neutral from Sell at UBS... New Jersey Resources (njr) upgraded to Buy from Neutral at Sidoti... Mid-America Apartment (MAA) upgraded to Buy from Neutral at Hilliard Lyons... Manulife Financial (MFC) upgraded to Sector Outperformer from Sector Performer at CIBC... Renasant (RNST) upgraded to Overweight from Equal Weight at Stephens... Guess (GES) upgraded to Outperform from Neutral at Wedbush... LinkedIn (LNKD) upgraded to Buy from Outperform at CLSA... International Game (IGT) upgraded to Buy from Hold at Argus... Activision Blizzard (ATVI) upgraded to Outperform from Neutral at Macquarie.
News For ACM;ARMH;AVB;BRE;BCS;BIIB;DFS;EQR;PCS;LRE;NTES;RNST;UDR;WLK;MAA;MFC;GES;LNKD;IGT;ATVI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 26, 2015
10:00 EDTARMHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARM Holdings (ARMH) downgraded to Underperform from Market Perform at Bernstein... Apogee Enterprises (APOG) downgraded to Market Perform from Outperform at Northland... Atlas Resource Partners (ARP) downgraded to Underperform from Neutral at BofA/Merrill... Bank of the Ozarks (OZRK) downgraded to Hold from Buy at Drexel Hamilton... China Cord Blood (CO) downgraded to Neutral from Buy at Roth Capital... Citizens Financial (CFG) downgraded to Neutral from Buy at Guggenheim... Community Health (CYH) downgraded to Market Perform from Outperform at Raymond James... Eagle Bancorp (EGBN) downgraded to Hold from Buy at Sandler O'Neill... Fifth Street Senior (FSFR) downgraded to Neutral from Buy at UBS... FireEye (FEYE) downgraded to Equal Weight from Overweight at Barclays... Insight Enterprises (NSIT) downgraded to Underperform at Raymond James... Micron (MU) downgraded to Neutral from Buy at Mizuho... SYNNEX (SNX) downgraded to Hold from Buy at Needham... Swatch Group (SWGAY) downgraded to Equal Weight from Overweight at Barclays... Target (TGT) downgraded to Market Perform from Outperform at BMO Capital... Zoetis (ZTS) downgraded to Market Perform from Outperform at BMO Capital.
07:06 EDTLNKDLinkedIn risk/reward compelling at current levels, says Cantor
Subscribe for More Information
06:54 EDTARMHARM Holdings downgraded to Underperform from Market Perform at Bernstein
Subscribe for More Information
05:21 EDTBIIBBiogen, Sobi announce EMA validates MAA for Alprolix
Biogen and Swedish Orphan Biovitrum AB, or Sobi, announced that the European Medicines Agency, or EMA, has accepted the Marketing Authorization Application, or MAA, of Alprolix, a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA’s review process. The MAA includes results from two global, Phase 3 clinical trials examining the efficacy, safety and pharmacokinetics of ALPROLIX for hemophilia B: the pivotal B-LONG study for previously treated adults and adolescents, and Kids B-LONG study for previously treated children under age 12.
June 25, 2015
16:48 EDTATVIActivision Blizzard initiated with a Buy at Mizuho
Subscribe for More Information
12:59 EDTBIIBOptions with increasing implied volatility
Subscribe for More Information
June 24, 2015
11:16 EDTBIIBOptions with increasing implied volatility
Options with increasing implied volatility: WMB AMZN CMG BIIB VMW QLIK ISRG FB UA FFIV
10:36 EDTATVIElectronic Arts advances after analysts positive on E3 showing
Subscribe for More Information
07:33 EDTACMHouse Transportation & Infrastructure Committee to hold a hearing
Subscribe for More Information
07:16 EDTWLKCredit Suisse to hold a conference
Subscribe for More Information
07:13 EDTATVIActivision Blizzard well positioned for upside, says Brean Capital
Subscribe for More Information
06:40 EDTBCSCalif. utility sues Barclays over electricity price manipulation, Reuters says
Subscribe for More Information
June 23, 2015
12:57 EDTBCSBarclays appoints Nomura’s Sherlund as software banking chair, Bloomberg says
Barclays (BCS) named Richard “Rick” Sherlund as chairman of software banking, Bloomberg reports, citing a company memo. Sherlund comes to the company from Nomura Holdings (NMR) where he worked for the past four years as a managing director and head of U.S. technology research, the report says.
11:00 EDTBIIBOptions with increasing implied volatility
Options with increasing implied volatility:TRIP WPZ CMG BIIB WMB AMZN ISRG VMW
07:55 EDTBIIBBiogen's Tysabri in SPMS a $1B-$2B opportunity, says Morgan Stanley
Subscribe for More Information
07:02 EDTARMHFreescale introduces MCU platform based on ARM Cortex-M class platform
Subscribe for More Information
06:53 EDTBCSPSAV prepares for IPO that could raise roughly $300M, Bloomberg says
Subscribe for More Information
06:30 EDTBCSBarclays experimenting with blockchain technology, Finextra reports
Subscribe for More Information
06:25 EDTBCSBarclays-Stifel deal marks end of Lehman legacy, Business Insider reports
Subscribe for More Information
06:21 EDTBCSBarclays may sell private equity business to management, Reuters reports
Barclays is in discussions to sell Barclays Natural Resource Investments, its natural resources-focused private equity business, to the unit's management, Reuters reports, citing a source familiar with the situation. Sky News previously reported that the talks are at an "advanced stage" and could be concluded this year. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use